Zacks.com on MSN2d
Here's Why you Should Retain Nevro Stock in Your Portfolio NowNVRO continues to gain due to its business expansion into the SI joint fusion market and optimistic 2024 results amid a weak SCS market.
Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 ...
Shares of NVRO stock opened at $5.80 on Friday. The stock has a market cap of $222.37 million, a price-to-earnings ratio of -3.07 and a beta of 0.94. The stock has a 50-day moving average of $5.18 ...
Op dinsdag handhaafden analisten van Stifel hun koopadvies en koersdoel van $ 94,00 voor aandelen van Globus Medical (NYSE:GMED), met focus op de fusierichtlijnen en potentiële winst per aandeel (EPS) ...
Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Wednesday, March 19 based on AAII’s Stock Grades.
Investing in any of the 11 sectors of the S&P 500 index could help anyone diversify their portfolio. Yesterday, we discussed using ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
After hours: March 20 at 7:56:51 p.m. EDT Loading Chart for IRTC ...
Pre-Market: 8:18:02 a.m. EDT Loading Chart for ADGM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback